This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bersin, R. M. Articles by Arieff, A. I. Search for Related Content PubMed PubMed Citation Articles by Bersin, R. M. Articles by Arieff, A. I.

Circulation, Vol 77, 227-233, Copyright © 1988 by American Heart Association

ARTICLES

Improved hemodynamic function during hypoxia with Carbicarb, a new agent for the management of acidosis

RM Bersin and AI Arieff
Department of Medicine, Veterans Administration Medical Center, San Francisco, CA.

Carbicarb is a mixture of Na2CO3/NaHCO3 that buffers similarly to NaHCO3, but without net generation of CO2. We studied the effects of carbicarb in an animal preparation of hypoxic lactic acidosis (HLA). HLA was induced by ventilating dogs with an hypoxic gas mixture (8% O2/92% N2). Dogs with HLA (n = 28) were then treated with 2.5 meq/kg of either NaHCO3 or carbicarb over 1 hr. Measurements were made, after 1 hr of hypoxia and 1 hr of therapy, of: cardiac hemodynamics, blood gases, liver intracellular pH (pHi), oxygen consumption, and regional lactate production. After therapy, the arterial pH rose with carbicarb (7.22 to 7.27, p less than .01), and fell with NaHCO3 (7.18 to 7.13, p less than .01). Mixed venous PCO2 did not change with carbicarb but increased with NaHCO3 (p less than .05). Arterial lactates stabilized with carbicarb but rose with NaHCO3 (by 3.1 mmol/liter, p less than .005). Lactate use by muscle, gut, and liver all improved with carbicarb and decreased with NaHCO3. The liver pHi (normal = 6.99, hypoxia = 6.80) improved with carbicarb (to 6.92), but decreased further with NaHCO3 (to 6.40). Muscle O2 consumption rose with carbicarb, whereas it decreased with NaHCO3. Arterial pressure fell less with carbicarb (-12 vs -46 mm Hg, p less than .006) and the cardiac output was stable with carbicarb but decreased with NaHCO3 (from 143 to 98 ml/kg/min, p less than .004). Stroke volume also improved with carbicarb but there was no change in pulmonary capillary wedge pressure, suggesting that carbicarb had a beneficial effect on myocardial contractility.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				P. J. Fall and H. M. Szerlip Lactic Acidosis: From Sour Milk to Septic Shock J Intensive Care Med, September 1, 2005; 20(5): 255 - 271. [Abstract] [PDF]

				B. Cuhaci, J. Lee, Z. Ahmed, S. M. Forsythe, and G. A. Schmidt Sodium Bicarbonate Controversy in Lactic Acidosis Chest, September 1, 2000; 118(3): 882 - 884. [Full Text] [PDF]

				S. M. Forsythe and G. A. Schmidt Sodium Bicarbonate for the Treatment of Lactic Acidosis* Chest, January 1, 2000; 117(1): 260 - 267. [Abstract] [Full Text] [PDF]

				H. J. Adrogue and N. E. Madias Management of Life-Threatening Acid-Base Disorders- First of Two Parts N. Engl. J. Med., January 1, 1998; 338(1): 26 - 34. [Full Text] [PDF]

				M. J. Rumbak Lactic Acidosis Ann Intern Med, August 1, 1990; 113(3): 254 - 256. [Abstract] [PDF]